| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8535017 | Life Sciences | 2018 | 30 Pages |
Abstract
LQFM030 seems to be a promising antitumor candidate for combinatory therapy with typical cytotoxic compounds, reducing the toxicity burden while allowing a superior anticancer activity. Moreover, these data also open new perspectives for LQFM030 as an antiangiogenic agent for treatment of diseases involving VEGF overexpression.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Mariana Flavia da Mota, Flávio Silva de Carvalho, Renato Ivan de Ávila, Paulo Henrique Marcelino de Ávila, Alane Pereira Cortez, Ricardo Menegatti, José Ricardo Sabino, Thais Rosa Marques dos Santos, Sandro Antônio Gomes, Luiz Carlos da Cunha,